A detailed history of Castle Rock Wealth Management, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Castle Rock Wealth Management, LLC holds 6,972 shares of IONS stock, worth $321,339. This represents 0.08% of its overall portfolio holdings.

Number of Shares
6,972
Previous 6,972 -0.0%
Holding current value
$321,339
Previous $352,000 14.2%
% of portfolio
0.08%
Previous 0.11%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

SELL
$38.5 - $47.13 $15,400 - $18,852
-400 Reduced 5.43%
6,972 $316,000
Q2 2023

Jul 10, 2023

SELL
$34.73 - $43.33 $417,211 - $520,523
-12,013 Reduced 61.97%
7,372 $302,000
Q4 2022

Jan 30, 2023

SELL
$37.12 - $46.52 $18,560 - $23,260
-500 Reduced 2.51%
19,385 $732,000
Q3 2022

Oct 13, 2022

BUY
$36.54 - $48.66 $156,829 - $208,848
4,292 Added 27.53%
19,885 $906,000
Q1 2021

Apr 27, 2021

BUY
$42.51 - $63.78 $31,032 - $46,559
730 Added 4.91%
15,593 $662,000
Q4 2020

Jan 29, 2021

BUY
$45.3 - $60.27 $673,293 - $895,793
14,863 New
14,863 $918,000
Q3 2020

Dec 07, 2020

SELL
$47.45 - $62.95 $724,229 - $960,805
-15,263 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$46.85 - $61.05 $18,740 - $24,420
400 Added 2.69%
15,263 $904,000
Q3 2019

Nov 13, 2019

BUY
$59.06 - $72.15 $877,808 - $1.07 Million
14,863 New
14,863 $842,000
Q2 2019

Aug 08, 2019

SELL
$62.09 - $86.14 $922,843 - $1.28 Million
-14,863 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$52.92 - $81.17 $10,584 - $16,234
200 Added 1.36%
14,863 $0
Q4 2018

Feb 11, 2019

BUY
$43.37 - $59.54 $635,934 - $873,035
14,663 New
14,663 $854,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $6.54B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Castle Rock Wealth Management, LLC Portfolio

Follow Castle Rock Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castle Rock Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castle Rock Wealth Management, LLC with notifications on news.